COLL - CIK 0001267565
COLLEGIUM PHARMACEUTICAL, INC trades as COLL and has a market capitalization of $1.13 B, making it the #2551 largest US-listed company by market value. In its fiscal 2025 annual report the company posted revenue of $780.57M, up 23.6% from the prior year and net income of $63.00M. This page tracks COLLEGIUM PHARMACEUTICAL, INC through 849 SEC filings, with financial statements and metrics updated as new reports are filed.
Over the last 9 fiscal years COLLEGIUM PHARMACEUTICAL, INC's revenue grew from $1.71M to $780.57M, a compound annual growth rate of 97.5%. Net profit margin expanded from -5504.1% to 8.1% over the same period - every figure below comes from the company's audited annual filings.
| Filing | Type | Filed |
|---|---|---|
| Insider trade | 4 | 2026-05-20 |
| Insider trade | 4 | 2026-05-18 |
| New insider ownership | 3 | 2026-05-18 |
| Insider sale notice | 144 | 2026-05-18 |
| Insider trade | 4 | 2026-05-18 |
| Insider trade | 4 | 2026-05-18 |
| Insider trade | 4 | 2026-05-18 |
| Insider trade | 4 | 2026-05-18 |
Collegium to Participate in 2026 Jefferies Global Healthcare Conference – Collegium Pharmaceutical Inc.
Collegium Completes Acquisition of AZSTARYS® from Corium Therapeutics – Collegium Pharmaceutical Inc.
Collegium Reports First Quarter 2026 Financial Results and Highlights Recent Company Progress – Collegium Pharmaceutical Inc.
To access the conference call, please dial (877) 407-8037 ( U.S. ) or (201) 689-8037 (International) and reference the “Collegium Pharmaceutical Q1 2026 Earnings Call.” An audio webcast will be accessible from the Investors section of the Company’s website: www.collegiumpharma.com . The webcast will be available for replay on the Company’s website approximately two hours after the event.
Collegium to Participate in Upcoming Investor Conferences – Collegium Pharmaceutical Inc.
The largest companies sharing COLLEGIUM PHARMACEUTICAL, INC's SEC industry classification (pharmaceutical preparations).
COLLEGIUM PHARMACEUTICAL, INC (COLL) has a market capitalization of $1.13 B as of 2026-06-10, ranking #2551 among US-listed companies.
COLLEGIUM PHARMACEUTICAL, INC reported revenue of $780.57M for fiscal year 2025, an increase of 23.6% year over year.
Yes. COLLEGIUM PHARMACEUTICAL, INC reported net income of $63.00M in its latest fiscal year.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.